Details of the Drug

General Information of Drug (ID: DMMGMBC)

Drug Name
CYTO-402
Indication
Disease Entry ICD 11 Status REF
Hepatocellular carcinoma 2C12.02 Phase 1 [1]
Cross-matching ID
TTD ID
DB9O4X

References

1 Clinical pipeline report, company report or official report of Cytocom